The Hunter Williams Podcast

Peptides, Prevention, and the Future of Longevity | My Fountain Life Experience

Dec 23, 2025
Dr. Bill Kapp, the CEO of Fountain Life and expert in preventive healthcare, joins to discuss the intriguing world of peptides and longevity. They explore the historical roots and clinical applications of peptides, including their potential to reduce metabolic inflammation. Hear about the impact of GLP-1 drugs on liver fat and metabolic markers. The conversation also delves into the importance of cycling growth hormone peptides to enhance effectiveness. Kapp shares insights on mitochondrial peptides and their role in combating aging.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Raise Growth Hormone By Signaling, Then Cycle

  • Consider growth-hormone-releasing peptides (e.g., sermorelin, tesamorelin) to raise endogenous GH rather than using exogenous GH long-term.
  • Cycle these peptides to avoid antibody formation, preserve sensitivity, and limit insulin resistance risks.
ADVICE

Cycle To Preserve Peptide Efficacy

  • Cycle GH-releasing peptides (e.g., 8–12 weeks on, similar period off) to avoid anti-drug antibodies and preserve efficacy.
  • Pulsing limits chronic elevation risks and reduces need for escalating doses.
INSIGHT

Different GH Peptides Complement Each Other

  • CJC/Tesamorelin/IPamorelin families hit growth-hormone pathways differently and pair synergistically.
  • Despite FDA caution, clinicians observe real-world benefits; choice often balances efficacy, side effects, and regulation.
Get the Snipd Podcast app to discover more snips from this episode
Get the app